Please login to the form below

Not currently logged in
Email:
Password:

Allergan opens Indian pharma R&D arm

US-headquartered Allergan has opened its first pharmaceutical R&D facility in India

According to local media reports, US-headquartered Allergan has opened its first pharmaceutical R&D facility in India.

The Allergan Pharmaceutical Development Centre India, which will make up part of Allergan's worldwide R&D operations, will focus on implementing global pharmaceutical R&D projects conducted in the region.

According to Scott M Whitcup, Allergan's worldwide executive vice-president of R&D, the centre would have 15 clinical research and data management personnel at the start of operations and could double within two years.

Whitcup said that Allergan's estimated investment for the new centre at USD 3m to USD 5m over the next few years. He added that R&D activities at the centre would initially focus on therapies in areas such as inflammatory and infective conditions of the eye, movement disorders and urological indications.

The centre is Allergan's third largest outside of the US. The company also has Allergan India, which manages the commercial side of Allergan's business there.

8th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Running
A marathon and a sprint
Customer experience is a long-distance race and with pharma late out of the blocks, companies need to put their foot down if they want to compete...
5 tactics to master Market Access
Is it time to rethink your game plan? To succeed at Market Access, follow these 5 tactics:...
Finding the patient voice
How patients feel and speak about clinical trials...

Infographics